Interferon Alfa, Human Recombinant
別名: Roferon-A, Intron-A, Alferon N
This medication is often used in an **'investigational' or off-label** manner in veterinary medicine. * **Expectations**: Please understand that its efficacy and safety have not been definitively established for all conditions in pets. * **Administration**: If you are giving this medication by mouth, it is usually a highly diluted liquid. Follow your veterinarian's exact dosing schedule (e.g., 7 days on, 7 days off). * **Storage**: Proper storage is critical. Keep refrigerated or frozen exactly as instructed by your veterinarian. Do not vigorously shake the solution. * **Side Effects**: Side effects are uncommon with oral use. If your pet receives injections, watch for signs of fever, lethargy, or muscle aches, and report them to your veterinarian.
劑量必須由獸醫按你寵物的個別情況決定。切勿在沒有獸醫指導下給予人類藥物或其他寵物的處方藥。
用途
- FeLV infection (Low dose)
- FeLV infection (High dose)
- FIV infection
- Chronic FHV-1 infections (Systemic)
- Chronic FHV-1 infections (Ophthalmic)
- Acute life-threatening FHV-1 infections in kittens
- Cutaneous T-cell lymphoma and severe cases of oral/cutaneous papillomas
- Immunostimulant for adjunctive treatment of dermatologic conditions (e.g., pododermatitis, papillomas, digital keratomas)
給藥方式
可能的副作用
- Malaise
- Fever
- Allergic reactions
- Myelotoxicity (anemia, leukopenia, thrombocytopenia)
- Myalgia
- Neutralizing antibody formation (in cats, leading to loss of efficacy)
- Hepatotoxicity (reported in humans)
- Neurotoxicity (reported in humans)
- Flu-like syndrome (reported in humans)
注意事項與禁忌
- Feline Infectious Peritonitis (FIP) - low dose oral therapy is contraindicated
- Preexisting autoimmune disease
- Severe cardiac disease
- Severe pulmonary disease
- 'Brittle' diabetes
- CNS disorders
- Known hypersensitivity to the drug
- When used parenterally, carefully weigh the **risks versus benefits** in patients with preexisting autoimmune disease, severe cardiac or pulmonary disease, 'brittle' diabetes, Herpes infections, or CNS disorders. * **Pregnancy**: Safety is not established (FDA Category C). High parenteral doses in monkeys increased abortifacient activity. * **Antibody Formation**: Prolonged parenteral use in cats (3-7 weeks) often leads to neutralizing antibodies, rendering the drug ineffective.
藥物相互作用
- Acyclovir: Additive or synergistic antiviral effects may occur.
- Zidovudine (AZT): Additive or synergistic antiviral effects may occur.
- Vidarabine: Increased toxicities may occur without synergistic antiviral effects.
常見問題
Interferon Alfa, Human Recombinant用於寵物有甚麼用途？
This medication is often used in an **'investigational' or off-label** manner in veterinary medicine. * **Expectations**: Please understand that its efficacy and safety have not been definitively established for all conditions in pets. * **Administration**: If you are giving this medication by mouth, it is usually a highly diluted liquid. Follow your veterinarian's exact dosing schedule (e.g., 7 days on, 7 days off). * **Storage**: Proper storage is critical. Keep refrigerated or frozen exactly as instructed by your veterinarian. Do not vigorously shake the solution. * **Side Effects**: Side effects are uncommon with oral use. If your pet receives injections, watch for signs of fever, lethargy, or muscle aches, and report them to your veterinarian.
Interferon Alfa, Human Recombinant對我的寵物安全嗎？
劑量必須由獸醫按你寵物的個別情況決定。切勿在沒有獸醫指導下給予人類藥物或其他寵物的處方藥。
本文僅供一般健康教育，不能取代專業獸醫意見。如寵物身體不適，請諮詢獸醫。